目的探讨螺旋CT动态增强扫描在肝细胞癌诊断中的应用价值。
Objective Study on dynamic contrast-enhanced spiral ct scan in diagnosis of hepatocellular carcinoma in the application.
目的探讨螺旋CT动态增强扫描在肝细胞癌诊断中的应用价值。
Objective Study on dynamic contrast-enhanced spiral ct scan in diagnosis of hepatocellular carcinoma in the application. Methods.
目的探讨低场MR平扫在肝细胞癌(HCC)的诊断与鉴别诊断中的价值。
To evaluate the diagnosis and differential diagnosis value of low-field MR plain scanning in hepatocellular carcinoma (HCC) and hemangioma.
在肝细胞癌中，OSU-2S的抗癌效应，FTY720的非免疫抑制性类似物。
Antitumor effects of OSU-2S, a nonimmunosuppressive analogue of FTY720, in hepatocellular carcinoma.
目的：比较表皮生长因子受体(EGFR)在肝细胞癌及胆管细胞癌中表达的差异。
Purpose to explore the difference in the expression of epidermal growth factor receptor (EGFR) between hepatocellular carcinoma and cholangiocarcinoma.
目的探讨血小板源性内皮细胞生长因子（PD-ECGF）在肝细胞癌的生长及转移中的意义。
Objective To investigate the effect of the platelet-derived endothelial cell growth factor(PD-ECGF) in growth and metastasis of hepatocellular carcinoma(HCC).
目的探讨CD 44V6和VEGF在肝细胞癌(HCC)中的表达及其在临床预后中的价值。
Objective to investigate expression of CD44 V6 and VEGF in hepatocellular carcinoma (HCC) and its clinical prognostic significance.
目的研究血小板反应蛋白1（TSP 1）和血管内皮生长因子（VEGF）的平衡在肝细胞癌（HCC）新生血管生成中的作用。
Objective To study the role of the balance between thrombospondin-1 (TSP-1) and vascular endothelial growth factor (VEGF) in the neovascularization of hepatocellular carcinoma (HCC).
联合这些分子标志物能帮助提高器官在HCV -肝细胞癌患者中的分配。
Incorporation of these molecular markers could help to improve organ allocation for HCV-HCC patients.
这一结果是令人鼓舞的，因为在最初治疗之后肝细胞癌反应的早期看法是必要的，以便改善预后和指导今后的治疗。
This result is encouraging because early knowledge of HCC response after initial therapy is essential to revise prognosis and guide future therapy.
目的：分析肝细胞癌在低场MR的征象。
在中国和远东，超过80%的肝细胞癌患者有慢性乙肝病毒的感染。
In parts of China and the Far East, over 80% of HCC patients have chronic HBV infection.
目的探讨肝细胞癌(HCC)在螺旋CT三期扫描中的不典型表现，并分析其产生原因。
Objective to analyze the cause of atypical manifestation of hepatocellular carcinoma (HCC) in triple-phase spiral ct enhanced scan.
目的通过检测肿瘤抑制基因产物pten蛋白在肝癌中的表达情况，探讨其作为一种评估肝细胞癌(HCC)生物学特征的分子标记的意义。
Objective to detect the expression of PTEN protein in hepatocellular carcinoma (HCC) to determine whether it can be used as a new molecular label for evaluation of biological characteristics of HCC.
分析33例手术病理证实的肝细胞癌在术前mri的边缘形态并对24例标本MRI与病理基础对照研究。
Method Tumor border patterns on MRI of 33 cases of HCC were analyzed, and MRI pathologic correlation study of 24 resected HCC specimens were performed.
目的：探讨人白细胞DR抗原(HLA- DR)在人原发性肝细胞癌(简称肝癌)的表达情况及其意义。
Objective: to require into the expression and significance of human leukocytic antigen DR (HLA - DR) in primary human hepatocellular carcinoma (HCC).
原发性肝细胞癌、转移性肝癌、局灶性结节增生、炎性假瘤在MRSP各期中表现不同。
Primary hepatic carcinoma, hepatic metastases, focal nodular hyperplasia, and inflammatory pseudotumor were presented as different MR features on each phase of MRSP.
目的在全基因组范围内筛选肝细胞癌候选诊断指标。
Objective to identify genes associated with hepatocellular carcinoma (HCC) as candidate diagnostic markers in a genome-wide scale.
在美国，静脉曲张出血发生率似乎在下降，而肝细胞癌发生率似乎在升高。
In the US the incidence of variceal hemorrhage seems to be declining, while the incidence of hepatocellular carcinoma seems to be increasing.
结论：这里我们鉴别了在等待肝移植的HCV -肝癌患者中，和肝细胞癌进展相关的基因。
CONCLUSIONS: Here, we have identified genes associated with HCC progression in HCV-HCC patients awaiting LT transplantation.
RT-PCR在92%的纤维板层型肝细胞癌病例（24/26）中是检测成功的，并在所有成功纤维板层型肝细胞癌中发现了DNAJB1-PRKACA融合转录体，而其它类型的肿瘤均未发现。
RT-PCR was successful in 92% of tested fibrolamellar carcinoma cases (24/26) and the DNAJB1-PRKACA fusion transcript was found in all fibrolamellar carcinomas but not in other tumor types.
其结果大多数癌除肝细胞肝癌、肾透明细胞癌外，大部分肿瘤细胞显示中等度到强阳性。在滑膜肉瘤、恶性间皮瘤及胸腺瘤上皮样成份弱阳性。
The majority of the carcinomas, except hepatocellular, adrenocortical clear cell ones are stained of strong or moderate intensity in the majority of tumor cells.
《国际肝病》：晚期肝细胞癌预后极差，在本病早期生物标志物病理诊断方面有什么新进展么？
Hepatology Digest: Advanced hepatocellular carcinoma carries a very bad prognosis, what is the latest developments in terms of biomarkers which can detect this pathology during its early stages.
方法：收集1995—2000年在复旦大学肝癌研究所行手术切除的355例肝细胞癌患者临床病理资料及术后随访资料。
Methods: a retrospective analysis of clinicopathological data of 355 patients with hepatocellular carcinoma who received hepatic resection in our hospital from 1995 to 2000.
《国际肝病》：在肝切除术后，如果有肝细胞癌复发，我们应该怎么做？
HEPATOLOGY DIGEST: What should we do when HCC recurrent after liver resection?
在Cox比例危险率模型中，等待时间也不是肝细胞癌复发的显著预测因子。
In the Cox proportional hazards model, waitlist time was also not a significant predictor of HCC recurrence.
纵使现在我们能使病毒在小鼠模型中长期生成，但问题是这些小鼠并未发生任何肝细胞癌，在其他动物模型中同样如此。
Even though we can now generate the virus in mouse models for a very long time the problem is that they do not get any hepatocellular carcinoma which is the same for other animal models.
目的比较原发性肝细胞癌(HCC)及其癌旁不同慢性病变组织端粒酶活性的异同，探讨端粒酶活性在恶性肿瘤诊断中的意义。
Objective to compare telomerase activity of hepatocellular carcinoma (HCC) with that of chronic liver disease to analyze the significance of telomerase activity in diagnosis of malignancy.
目的比较原发性肝细胞癌(HCC)及其癌旁不同慢性病变组织端粒酶活性的异同，探讨端粒酶活性在恶性肿瘤诊断中的意义。
Objective to compare telomerase activity of hepatocellular carcinoma (HCC) with that of chronic liver disease to analyze the significance of telomerase activity in diagnosis of malignancy.
应用推荐